Risk stratification in the management of atrial fibrillation in the community

British Journal of General Practice

Volumn 49, Issue 441, 1999, Pages 295-296

  Fahey, Tom ^b   Rimmer, James ^a   Godfrey, Peter ^a  

^a Avon Primary Care Research Collaborative   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Antithrombotic therapy; Atrial fibrillation; Risk assessment

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DIGOXIN; WARFARIN;

ADULT; AGE; AGED; ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; STROKE;

AGED; AGED, 80 AND OVER; ASPIRIN; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FAMILY PRACTICE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; THROMBOLYTIC THERAPY; WARFARIN;

EID: 0032942613     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994; 154: 1449-1457.
2. Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atria fibrillation. Analysis of pooled data from three randomized trials. Arch Intern Med 1997; 157: 1237-1240.
3. Glasziou P, Irwig L. An evidence based approach to individualising treatment. BMJ 1995; 311: 1356-1359.
4. Sudlow M, Rodgers H, Kenny RA, Thomson R. Population based study of use of anticoagulants among patients with atrial fibrillation in the community. BMJ 1997; 314: 1529-1530.
5. Langenberg M, Hellemons B, van Ree J, et al. Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice. BMJ 1996; 313: 1534.